Maastricht Crossover Trial Shows 16-Week Peanut Intake Boosts Regional Brain Insulin Responsiveness

The NUTRIM study at Maastricht University used arterial spin labeling MRI to measure regional cerebral blood flow responses to intranasal insulin before and after each 16-week period. Participants consumed two daily servings of peanuts or maintained their usual diet in counterbalanced order. Whole-brain analysis isolated one significant cluster where post-peanut insulin responsiveness rose relative to control, encompassing memory-related structures. Cognitive testing via CANTAB and prior global CBF gains of 3.6 percent from the same cohort indicate vascular and metabolic pathways may converge on memory circuits.

Peanuts supply L-arginine for nitric oxide synthesis, unsaturated fats, and polyphenols that prior observational cohorts have linked to slower cognitive decline. The 2025 Clinical Nutrition paper from the same group already reported verbal memory gains of 5.8 percent after identical intake, suggesting the insulin-sensitivity shift may mediate those effects. However, the modest sample and short duration leave open whether benefits persist or translate to reduced Alzheimer incidence in higher-risk groups.

Next steps require a multicenter RCT powered for clinical endpoints such as incident mild cognitive impairment over 24 months, with stratification by baseline insulin resistance. Parallel mechanistic work should quantify nitric oxide metabolites and hippocampal volume change to test causality beyond surrogate CBF measures.